Left Atrial Appendage Closure With SentreHeart Lariat® Device "Lariat"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

The study cohort will consist of up to 50 patients who are candidates for Left Atrial Appendage (LAA) closure in whom oral anticoagulation is contraindicated. Subjects evaluated for left atrial appendage closure will be screened for inclusion and consented prior to their procedure. If the anatomy is favorable for placement of the Lariat® device, the procedure will be performed at one of the participating...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 January 2018.

1 Mar 2015 26 May 2015 1 Mar 2019 1 Mar 2019 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Single Group Assignment